Bioqube Ventures is a specialist life sciences venture capital investor investing in European biotechnology companies
Business Model:
Revenue: $0
Employees: 2-10
Address:
City:
State:
Zip:
Country:
Bioqube Ventures is a specialist life sciences venture capital fund investing in European biotech companies developing innovative therapeutic assets and technologies. We put our venture creation experience at work to translate and de-risk scientific innovation, advancing our investment portfolio and maximising value for investors. Bioqube Ventures invests through its independent fund “Bioqube Factory Fund I”: … an early stage venture capital fund – dedicated to advancing exciting science in vibrant European ecosystems to breakthrough therapies for patients. … a fit-for-purpose dual investment model – besides more classical investments in first investment rounds, we will have special attention for so called “Create” projects that require additional de-risking prior to creating new ventures. … a hands-on approach – the team is a mix of fund managers, sector experts and serial entrepreneurs that have a proven track record in successfully leading companies on their growth paths. Medtech, healthtech and diagnostics are not part of our current investment scope.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
9/2022 | Tridek-One | Venture Round | 0 |
10/2021 | Egle Therapeutics | Series A | 0 |
1/2021 | Primmune Therapeutics | Series A | 0 |
3/2023 | Bicara Therapeutics | Series B | 0 |
4/2021 | Anavo Therapeutics | Seed Round | 0 |
10/2022 | Enhanc3D Genomics | Series A | 11.2M |
1/2021 | Enhanc3D Genomics | Seed Round | - |
10/2021 | Egle Therapeutics | Series A | 0 |
4/2021 | Anavo Therapeutics | Seed Round | 0 |
1/2021 | Primmune Therapeutics | Series A | 0 |
1/2021 | Enhanc3D Genomics | Seed Round | - |
Name | Price |
---|
Name | Size | Announced Date |
---|